HRSV Post-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development)

• Background:

  Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a rapid and effective assay kit detecting the specific levels of HRSV Post-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines.

• Description:

  HRSV Post-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development) is expressed from HRSV

• Reactivity:

  HRSV

• Target:

  Post-Fusion glycoprotein F0

• Applications:

  It was developed for the specific quantitative detection of HRSV Post-Fusion glycoprotein in samples.

• Stability:

  1. Unopened kit should be stored at 2°C-8°C upon receiving. 2. Find the expiration date on the outside packaging and do not use reagents past their expiration date. 3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

• Format:

  Solid

• Components:

  This assay kit employs a standard sandwich-ELISA format, providing a rapid detection of Post-Fusion glycoprotein F0 (RSV). The kit consists of Pre-coated Anti-Post-Fusion glycoprotein F0 (RSV) Antibody Microplate and Post-Fusion glycoprotein F0 (RSV) Standard,HRP-Anti-RSV-F0 Antibody and buffers.

• Shipping Conditions:

  RT

• Storage Conditions:

  2-8°C

• Package Size:

  96tests*1

• Species:

  HRSV

• CAS Number:

  7732-18-5